Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

• By Mandy Jackson

Biopharma In Perspective 2016-2017

Related Content

IPO Update: TiGenix Debuts In December After Motif Launched In November As 2016 Offerings Best 2015

Dec 14 2016

Related Companies

Novan, Inc.

AveXis, Inc.

Merus N.V.

Reata Pharmaceuticals, Inc.

Protagonist Therapeutics, Inc.

PhaseRx, Inc.

Moleculin Biotech, Inc.

Spyre Therapeutics, Inc.

Kadmon Holdings, Inc.

Outlook Therapeutics, Inc.

Jounce Therapeutics, Inc.

ObsEva SA

Apple Tree Partners

Takeda Pharmaceutical Co. Ltd.

Motif Bio plc

Myovant Sciences Ltd.

Ra Pharmaceuticals, Inc.

CRISPR Therapeutics AG

Entero Therapeutics, Inc.

AC Immune SA

Novan, Inc.

Protagonist Therapeutics, Inc.

Gemphire Therapeutics, Inc.

Astellas Gene Therapies

Syros Pharmaceuticals, Inc.

Selecta Biosciences, Inc.

Clearside Biomedical, Inc.

Moleculin Biotech, Inc.

Reata Pharmaceuticals, Inc.

Merus N.V.

PhaseRx, Inc.

Outlook Therapeutics, Inc.

Spring Bank Pharmaceuticals Inc.

Intellia Therapeutics, Inc.

Spyre Therapeutics, Inc.

Corvus Pharmaceuticals, Inc.

HUTCHMED (China) Limited

Syndax Pharmaceuticals, Inc.

Proteostasis Therapeutics, Inc.

AveXis, Inc.

Editas Medicine

BeOne Medicines Ltd.

Additional Topics

StartUps and SMEs Financing Companies Commercial BioPharmaceutical

More from Start-Ups & SMEs

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window